Document Detail


Major basic protein as a marker of malignant potential in trophoblastic neoplasia.
MedLine Citation:
PMID:  8828426     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: We tested whether serum pregnancy-associated major basic protein levels distinguish between benign and malignant trophoblastic disease. STUDY DESIGN: We compared serum pregnancy-associated major basic protein levels in seven patient groups: nonpregnant and pregnant controls, partial moles, complete moles, persistent moles, placental-site trophoblastic tumors, and choriocarcinoma. RESULTS: The results showed that patients with partial and complete moles had elevated serum pregnancy-associated major basic protein levels comparable to normal pregnancy. In contrast, patients with persistent mole, placental-site trophoblastic tumors and choriocarcinoma had low median serum levels comparable to those of the nonpregnant controls. Significant differences were shown between the complete and persistent mole groups (p = 0.0001) and between the complete mole group and the choriocarcinoma group (p = 0.0001); however, persistent moles were indistinguishable from choriocarcinoma (p = 0.2010). CONCLUSION: Serum pregnancy-associated major basic protein levels thus distinguish between benign disorders, such as pregnancy and partial and complete moles, and trophoblastic tumors, such as persistent moles and choriocarcinoma. The absence of elevated serum levels of pregnancy-associated major basic protein may be useful clinically to indicate a more aggressive or frankly malignant tumor.
Authors:
K V Gurian; K C Podratz; S A Elg; L B Twiggs; J R Lurain; J M Wagner; G J Gleich
Related Documents :
3429106 - Immunocytochemical localization of chorionic gonadotropin, placental lactogen, and plac...
12166356 - Generalized gingival hyperplasia occurring during pregnancy.
10525376 - Repetitive hydatidiform mole with different male partners.
9159446 - Intracytoplasmic sperm injection combined with preimplantation genetic diagnosis for th...
9743876 - Pregnancy and delivery in a group of israeli teenagers. a case-controlled study.
7279346 - Pulmonary eosinophilic granuloma complicating pregnancy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  175     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1996 Sep 
Date Detail:
Created Date:  1996-11-04     Completed Date:  1996-11-04     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  632-7     Citation Subset:  AIM; IM    
Affiliation:
Department of Obstetrics, Mayo Clinic, Rochester, MN 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Proteins
Choriocarcinoma / blood
Chorionic Gonadotropin, beta Subunit, Human / blood
Eosinophil Granule Proteins
Female
Fluorescent Antibody Technique
Humans
Immunoradiometric Assay
Pregnancy
Ribonucleases*
Time Factors
Trophoblastic Neoplasms / blood*
Trophoblastic Tumor, Placental Site / blood
Tumor Markers, Biological / blood*
Uterine Neoplasms / blood
Grant Support
ID/Acronym/Agency:
AI 09728/AI/NIAID NIH HHS; AI 15231/AI/NIAID NIH HHS; HD 22924/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Blood Proteins; 0/Chorionic Gonadotropin, beta Subunit, Human; 0/Eosinophil Granule Proteins; 0/Tumor Markers, Biological; EC 3.1.-/Ribonucleases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Blood flow changes in the ovarian and uterine arteries during the normal menstrual cycle.
Next Document:  Changes of plasma calcitonin gene-related peptide levels in postmenopausal women.